AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
A Stanford-led study published in Nature on Feb. 26 found that age-related changes witnessed in diseases like Alzheimer’s may be related to a relatively untapped area of research in the brain. The ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...